Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
GVBT similar filings
- 26 Mar 20 Unregistered Sales of Equity Securities
- 3 Aug 17 Index to Consolidated Financial Statements
- 18 May 17 Amendments to Articles of Incorporation or Bylaws
- 12 May 17 Index to Consolidated Financial Statements
- 4 May 17 Departure of Directors or Certain Officers
- 12 Oct 16 Changes in Registrant's Certifying Accountant
- 11 Oct 16 Amendments to Articles of Incorporation or Bylaws
Filing view
External links
EXHIBIT 16.1
May 12, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Ladies and Gentlemen:
Green Vision Biotechnology Corp., (the “Company”) provided to us a copy of the Company’s response to Item 4.01 of Form 8-K, dated May 12, 2017. We have read the Company’s statements included under Item 4.01 of its Form 8-K and we agree with such statements insofar as they relate to our firm.
Yours truly,
/s/ LBB & ASSOCIATES LTD., LLP
LBB & ASSOCIATES LTD., LLP